Price
Target price
€21.58
€21.58
-1.400%
-0.3
-1.400%
€24.90
26.06.26 / Tradegate
WKN: A2N6BH / Symbol: ELAN / Name: Elanco Animal Health / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Elanco Animal Health Inc. Stock
A loss of -1.400% shows a downward development for Elanco Animal Health Inc..
The stock is an absolute favorite of our community with 26 Buy predictions and no Sell predictions.
With a target price of 24 € there is a slightly positive potential of 11.21% for Elanco Animal Health Inc. compared to the current price of 21.58 €.
Pros and Cons of Elanco Animal Health Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Elanco Animal Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc. | -1.400% | 2.081% | 5.940% | 76.856% | 11.663% | 131.545% | -26.423% |
| BioMarin Pharmaceutical Inc. | -0.420% | 7.843% | 15.123% | 9.970% | 1.847% | -38.050% | -26.986% |
| Biogen Inc. | -0.060% | 10.992% | 12.040% | 76.267% | 26.687% | -26.476% | -34.808% |
| Zoetis Inc. A | -2.810% | -3.104% | -2.282% | -49.925% | -37.779% | -57.097% | -57.384% |
Comments
Elanco Animal Health (ELAN) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health (ELAN) had its price target raised by TD Cowen from $31.00 to $32.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health (ELAN) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Show more
Ratings data for ELAN provided by MarketBeat